UK Campaign to Stop Genetically Modified Human Embryos
By Marcy Darnovsky,
Genetic Crossroads
| 02. 28. 2007
The UK-based Human Genetics Alert (HGA) has launched a campaign to prevent Britain from becoming the first country in the world to sanction the production of genetically modified human embryos. As reported in the January issue of Genetic Crossroads, a bill set to be introduced would allow British scientists to begin developing technologies that could be used in efforts toward inheritable genetic modification.
Speaking at an HGA press conference, Dr. Richard Nicholson, editor of the Bulletin of Medical Ethics, said, "Every country that has legislated on this subject has banned it. Thus the British Government's decision breaks ranks with the international community, and may lead to the perception that Britain is a haven for irresponsible and profit-driven scientists."
The proposed law maintains the UK's existing ban on creating genetically modified children. But although the white paper supporting the proposed legislation says that genetically altering eggs, sperm and embryos "should not be permitted for reproductive purposes," it adds that this is only "for the foreseeable future, and until such time as safety and efficacy are assured."
HGA Director Dr...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...